World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
20054
World Ranking
18126
National Ranking
9034

Jane L. Messina publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jane L. Messina sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 363 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jane L. Messina D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jane L. Messina sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jane L. Messina is affiliated with the University of South Florida in the United States and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research is primarily concentrated in oncology, molecular biology, immunology, epidemiology, and dermatology.

The scientist's work spans several main topics including cutaneous melanoma detection and management, CAR-T cell therapy research, immunotherapy and immune responses, cancer immunotherapy and biomarkers, melanoma and MAPK pathways, cutaneous lymphoproliferative disorders research, and polyomavirus and related diseases.

Jane L. Messina's frequent collaborators include Vernon K. Sondak, Jonathan S. Zager, Amod A. Sarnaik, Ahmad A. Tarhini, and Zeynep Eroglu. These coauthors have contributed in multiple joint publications, reflecting ongoing collaborative research efforts.

Publication venues that regularly feature their work include Annals of Surgical Oncology, Cancer Research, Cancer, Annals of Oncology, and Hand Surgery & Rehabilitation.

Recent research papers authored by or associated with Jane L. Messina cover a range of topics and were published in respected journals:

  • Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases (2021, Clinical Cancer Research)
  • Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial (2022, The Lancet)
  • Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions (2023, JAMA Network Open)
  • Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients (2023, Cancer)
  • Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy (2023, Nature Cancer)

Best Publications

  • Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

    David H. Munn;Madhav D. Sharma;Deyan Hou;Babak Baban

  • Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

    Adil I. Daud;Ronald C. DeConti;Stephanie Andrews;Patricia Urbas

  • Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma

    John Albertini;C. Cruse;David Rapaport;Karen Wells

  • PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression

    Kim H.T. Paraiso;Yun Xiang;Vito W. Rebecca;Ethan V. Abel

  • 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

    Jane L. Messina;David A. Fenstermacher;Steven Eschrich;Xiaotao Qu

  • Guidelines of care for the management of cutaneous squamous cell carcinoma

    Murad Alam;April Armstrong;Christian Baum;Jeremy S. Bordeaux

  • Molecular staging of malignant melanoma: correlation with clinical outcome.

    Steven C. Shivers;Xiangning Wang;Weiguo Li;Emmanuella Joseph

  • Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

    Richard Heller;Mark J. Jaroszeski;L. Frank Glass;Jane L. Messina

  • Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy

    K H T Paraiso;I V Fedorenko;L P Cantini;A C Munko

  • Primary mucosal melanoma

    Ronald J. Patrick;Neil A. Fenske;Jane L. Messina

  • Interleukin-1 Receptor Antagonist Decreases Severity of Experimental Acute-Pancreatitis

    James Norman;Michael Franz;Jane Messina;Adam Riker

  • High response rate to PD-1 blockade in desmoplastic melanomas

    Zeynep Eroglu;Zeynep Eroglu;Jesse M. Zaretsky;Siwen Hu-Lieskovan;Dae Won Kim;Dae Won Kim

  • Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

    Christopher K. Bichakjian;Thomas Olencki;Sumaira Z. Aasi;Murad Alam

  • Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

    Dale Han;Jonathan S. Zager;Yu Shyr;Heidi Chen

  • Paradoxical oncogenesis—the long-term effects of BRAF inhibition in melanoma

    Geoffrey T. Gibney;Jane L. Messina;Inna V. Fedorenko;Vernon K. Sondak

  • Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.

    Carlos N. Prieto-Granada;Thomas Wiesner;Jane L. Messina;Achim A. Jungbluth

  • Age-Specific Seroprevalence of Merkel Cell Polyomavirus, BK Virus, and JC Virus

    Raphael P. Viscidi;Dana E. Rollison;Vernon K. Sondak;Barbara Silver

  • Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

    Rodabe N. Amaria;Alexander M. Menzies;Alexander M. Menzies;Alexander M. Menzies;Elizabeth M. Burton;Richard A. Scolyer;Richard A. Scolyer

  • Decreased mortality of severe acute pancreatitis after proximal cytokine blockade.

    James G. Norman;Michael G. Franz;Gregory S. Fink;Jane Messina

  • Abstract 5370: PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression

    Kim H. Paraiso;Vito Rebecca;Inna V. Fedorenko;Yun Xiang

Frequent Co-Authors

Vernon K. Sondak
Vernon K. Sondak University of South Florida
Douglas S. Reintgen
Douglas S. Reintgen University of South Florida
John M. Koomen
John M. Koomen University of South Florida
Anna R. Giuliano
Anna R. Giuliano University of South Florida
Massimo Tommasino
Massimo Tommasino International Agency For Research On Cancer
Adil Daud
Adil Daud University of California, San Francisco
Michael Pawlita
Michael Pawlita German Cancer Research Center
Jeffrey S. Weber
Jeffrey S. Weber New York University
Louis B. Harrison
Louis B. Harrison Moffitt Cancer Center
Alan B. Cantor
Alan B. Cantor Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA doesn't just mean earning an MD. There are diverse online programs that support various career pathways in healthcare, each with unique benefits and entry points.

For those interested in leadership roles, healthcare administration degree programs offer training in healthcare policy, finance, and management. If you're a registered nurse aiming to advance your practice, consider adn to np programs online, which can help you become a nurse practitioner through flexible, accelerated coursework.

Nutrition and wellness careers are also in demand. With online nutrition degree programs, you can learn about dietetics, public health, and how nutrition impacts patient care. Those seeking advanced credentials in healthcare administration may opt for cahme accredited online healthcare administration programs, designed to meet quality standards and expand job prospects in executive positions.

These online degrees allow for flexible study and can open doors to rewarding opportunities in patient care, management, and beyond.

Best Scientists Citing Jane L. Messina

Trending Scientists

Recently Published Articles